You are here:

flecainide 200mg caps (Tambocor XL)

Advice

Following an abbreviated submission

flecainide capsules (Tambocor XL) are accepted for use in NHS Scotland for: the treatment of AV nodal reciprocating tachycardia, arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways; paroxysmal atrial fibrillation in patients with disabling symptoms when treatment need has been established and in the absence of left ventricular dysfunction. Arrhythmias of recent onset will respond more readily. The capsules can be used for the maintenance of normal rhythm following conversion by other means.

Patients for whom the use of flecainide is appropriate and who are controlled on 200mg daily using the immediate release formulation may be transferred to one 200mg XL capsule with the benefit of once-daily rather than twice-daily dosing at reduced cost.

Drug Details

Drug Name: flecainide 200mg caps (Tambocor XL)
SMC Drug ID: 521/08
Manufacturer: Meda Pharmaceuticals Ltd
Indication: AV nodal reciprocating tachycardia, arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways
BNF Category:
Sub Category: 2.3 Anti-arrhythmic drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 8 December 2008

Back